AML Medical Science Liaison – Midwest-Central

IQVIA; Omaha (NE); Remote; USD 170,000 - 210,000; Full time

Job summary

IQVIA is seeking experienced Medical Science Liaisons to support a late-stage AML program. The role involves scientific exchange, data communication, and collaboration with hematology/oncology investigators and healthcare professionals across the assigned territory.

The MSL will engage with investigators, provide technical support for study development, and contribute to Medical Affairs and clinical development objectives while traveling up to 70% of the time.

Qualifications

• Advanced clinical or scientific degree required.
• Minimum of 4 years of Medical Science Liaison (MSL) experience or relevant clinical experience.
• Minimum 3 years of experience in hematology/oncology.
• Demonstrated track record in medical affairs or clinical development.
• Strong understanding of oncology treatment landscapes and stakeholders.
• Proficiency with CRM, MS Office, and digital engagement tools.
• Ability to travel extensively (up to 70%).

Responsibilities

• Develop and maintain scientific relationships with KOLs, investigators, and oncology centers.
• Engage in compliant scientific discussions about AML and related malignancies.
• Communicate complex clinical data clearly to diverse audiences.
• Support disease-state education, advisory boards, and investigator meetings.
• Execute scientific exchange with HCPs, formulary committees, and key stakeholders.
• Identify educational needs and opportunities for investigators.
• Provide technical support for study development and investigator-initiated research.

Skills

MSL experience

Hematology/Oncology

Scientific communication

CRM platforms

Microsoft Office

Microsoft Teams

Education

PharmD, MD, DO, PhD, DNP, NP, PA or equivalent

Tools

CRM platforms

Microsoft Office

Microsoft Teams

Job description

IQVIA is seeking experienced Medical Science Liaisons to support a late-stage AML program. The role involves scientific exchange, data communication, and collaboration with hematology/oncology investigators and healthcare professionals across the assigned territory.

The MSL will engage with investigators, provide technical support for study development, and contribute to Medical Affairs and clinical development objectives while traveling up to 70% of the time.